MedTrace Logo

Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients

NCT00599352 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2013-05-30

No results posted yet for this study

Summary

The purpose of this study is to determine how common low levels of magnesium are in patients with end stage liver disease. In addition, investigator is trying to determine if low levels of magnesium affect the release of parathyroid hormone in patients with end stage liver disease and low vitamin D levels

Conditions

Interventions

DIETARY_SUPPLEMENT

magnesium

Single infusion of elemental magnesium given over 4 hours, 0.2mEq/kg (2.4 mg/kg)

Sponsors & Collaborators

  • Rajib Bhattacharya, MD

    lead OTHER

Principal Investigators

  • Rajib Bhattacharya, MD · University of Kansas Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00599352 on ClinicalTrials.gov